[HTML][HTML] Progress and challenges in the development of COVID-19 vaccines and current understanding of SARS-CoV-2-specific immune responses

KD Kim, I Hwang, KB Ku, S Lee, SJ Kim… - Journal of microbiology …, 2020 - ncbi.nlm.nih.gov
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared …

SARS-CoV-2 targets and COVID-19 vaccines

AW Currier, MC Jeshurin, VB Sampson - COVID, 2021 - mdpi.com
Coronavirus disease-2019 (COVID-19) vaccines are being used across the globe to reduce
the risk of developing COVID-19, stop the transmission of severe acute respiratory syndrome …

Promise and challenges in the development of COVID-19 vaccines

W Chen - Human Vaccines & Immunotherapeutics, 2020 - Taylor & Francis
The pandemic outbreak of COVID-19, caused by coronavirus SARS-CoV-2, created an
unprecedented challenge to global public health system and biomedical community …

[HTML][HTML] The immunology of SARS-CoV-2 infections and vaccines

L Grigoryan, B Pulendran - Seminars in immunology, 2020 - Elsevier
Abstract SARS-CoV-2, the virus that causes COVID-19, emerged in late 2019, and was
declared a global pandemic on March 11th 2020. With over 50 million cases and 1.2 million …

Immunological considerations for COVID-19 vaccine strategies

M Jeyanathan, S Afkhami, F Smaill, MS Miller… - Nature Reviews …, 2020 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to …

[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development

R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …

Vaccines for COVID-19: a systematic review of immunogenicity, current development, and future prospects

Z Zhang, Q Shen, H Chang - Frontiers in immunology, 2022 - frontiersin.org
The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …

Coronavirus disease 2019 vaccine development: an overview

R Sumirtanurdin, MI Barliana - Viral immunology, 2021 - liebertpub.com
To this day, the coronavirus disease 2019 (COVID-19) pandemic has not shown signs of
abating. Moreover, the virus responsible for the pandemic, severe acute respiratory …

[HTML][HTML] Targets and strategies for vaccine development against SARS-CoV-2

JA Malik, AH Mulla, T Farooqi, FH Pottoo… - Biomedicine & …, 2021 - Elsevier
Abstract The SARS-CoV-2, previously called a novel coronavirus, that broke out in the
Wuhan city of China caused a significant number of morbidity and mortality in the world. It is …

[HTML][HTML] Current advances in the development of SARS-CoV-2 vaccines

A Awadasseid, Y Wu, Y Tanaka… - International journal of …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is now a global pandemic that has wreaked havoc …